Men's Health
Acetaminophen and prostate cancer
Aspirin is the oldest member of a large group of nonsteroidal anti-inflammatory drugs (NSAIDs). Aspirin is also the safest of these drugs, since it's the only member of the group that does not increase the risk of heart attack and stroke. And a meta-analysis of 17 studies of aspirin linked the drug to a 17% reduction in the risk of prostate cancer. Other research suggests that various nonaspirin NSAIDs are also capable of reducing the risk of cancer. Twelve studies of nonaspirin NSAIDs reported a 10% reduction in the risk of prostate cancer.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
